1018 related articles for article (PubMed ID: 21482744)
1. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
[TBL] [Abstract][Full Text] [Related]
2. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.
Waheed S; Matsushita K; Astor BC; Hoogeveen RC; Ballantyne C; Coresh J
Clin J Am Soc Nephrol; 2013 Mar; 8(3):434-42. PubMed ID: 23258794
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin concentration and risk of end-stage renal disease: the REGARDS study.
Walther CP; Gutiérrez OM; Cushman M; Judd SE; Lang J; McClellan W; Muntner P; Sarnak MJ; Shlipak MG; Warnock DG; Katz R; Ix JH
Nephrol Dial Transplant; 2018 Oct; 33(10):1770-1777. PubMed ID: 29281114
[TBL] [Abstract][Full Text] [Related]
4. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
5. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).
Shastri S; Katz R; Shlipak MG; Kestenbaum B; Peralta CA; Kramer H; Jacobs DR; de Boer IH; Cushman M; Siscovick D; Sarnak MJ
Am J Kidney Dis; 2011 Jun; 57(6):832-40. PubMed ID: 21296473
[TBL] [Abstract][Full Text] [Related]
8. Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA).
Garimella PS; Ix JH; Katz R; Shlipak MG; Criqui MH; Siscovick DS; Kramer H; Sibley CT; Sarnak MJ
Am J Kidney Dis; 2015 Jan; 65(1):33-40. PubMed ID: 24998036
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.
Carrero JJ; Grams ME; Sang Y; Ärnlöv J; Gasparini A; Matsushita K; Qureshi AR; Evans M; Barany P; Lindholm B; Ballew SH; Levey AS; Gansevoort RT; Elinder CG; Coresh J
Kidney Int; 2017 Jan; 91(1):244-251. PubMed ID: 27927597
[TBL] [Abstract][Full Text] [Related]
10. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C as a risk factor for outcomes in chronic kidney disease.
Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
[TBL] [Abstract][Full Text] [Related]
14. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
Bhavsar NA; Appel LJ; Kusek JW; Contreras G; Bakris G; Coresh J; Astor BC;
Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C, albuminuria, and mortality among older adults with diabetes.
de Boer IH; Katz R; Cao JJ; Fried LF; Kestenbaum B; Mukamal K; Rifkin DE; Sarnak MJ; Shlipak MG; Siscovick DS
Diabetes Care; 2009 Oct; 32(10):1833-8. PubMed ID: 19587367
[TBL] [Abstract][Full Text] [Related]
16. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis.
Fisher H; Hsu CY; Vittinghoff E; Lin F; Bansal N
Am J Kidney Dis; 2013 Dec; 62(6):1102-8. PubMed ID: 24041612
[TBL] [Abstract][Full Text] [Related]
17. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT
JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795
[TBL] [Abstract][Full Text] [Related]
18. The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic population.
Lamb EJ; Brettell EA; Cockwell P; Dalton N; Deeks JJ; Harris K; Higgins T; Kalra PA; Khunti K; Loud F; Ottridge RS; Sharpe CC; Sitch AJ; Stevens PE; Sutton AJ; Taal MW;
BMC Nephrol; 2014 Jan; 15():13. PubMed ID: 24423077
[TBL] [Abstract][Full Text] [Related]
19. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
[TBL] [Abstract][Full Text] [Related]
20. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).
Amin AP; Whaley-Connell AT; Li S; Chen SC; McCullough PA; Kosiborod MN;
Am J Kidney Dis; 2013 Apr; 61(4 Suppl 2):S12-23. PubMed ID: 23507266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
